Welcome to our dedicated page for Avepoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AvePoint, Inc. (AVPT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information about AvePoint’s financial results, capital markets activity, and material corporate events related to its role as a provider of data security, governance, and resilience solutions for SaaS and cloud collaboration platforms.
Investors can use AvePoint’s 8-K filings to review press releases that are furnished as exhibits, such as quarterly financial results and announcements about underwriting agreements and public offerings connected to the company’s listing on the Singapore Exchange. For example, AvePoint has filed Form 8-K reports to furnish its second and third quarter financial results and to disclose the underwriting agreement and offering terms associated with its SGX listing. These documents complement the company’s annual and quarterly reports on Forms 10-K and 10-Q, which contain broader discussions of financial condition, risk factors, and business operations.
The filings page also reflects corporate actions related to listing status. A Form 25 filing, for instance, documents the removal from listing and registration on Nasdaq of a class of AvePoint warrants under Section 12(b) of the Securities Exchange Act of 1934. Such filings help investors understand changes in how specific AvePoint securities trade and are registered.
On Stock Titan, AvePoint filings are paired with AI-powered summaries that explain the significance of each document in clear language. Users can quickly see the main points of earnings-related 8-Ks, offerings, and listing changes, while still having direct access to the full text on EDGAR. This combination of real-time updates, insider-relevant forms such as 8-K and 25, and AI-generated insights helps investors and analysts follow AvePoint’s regulatory history and ongoing disclosure practices more efficiently.
AvePoint, Inc. Executive Chairman Gong Xunkai reported mixed equity transactions in company common stock. On March 5, 2026, he acquired 44,439 shares of common stock at $11.29 per share through a grant or award, increasing his direct holdings.
On the same date, 48,539 shares of common stock at $11.29 per share were disposed of in an exempt tax-withholding transaction related to equity vesting, which the company executed to cover income tax obligations rather than a discretionary sale. After these moves, he directly owned 749,077 shares, including previously granted restricted stock units and performance-based RSUs subject to vesting and performance conditions.
AvePoint, Inc. director and Chief Executive Officer Tianyi Jiang reported equity compensation activity involving the company’s common stock. On March 5, 2026, he acquired 44,439 shares at $11.29 per share through a grant or award, including performance-based restricted stock units subject to vesting and performance conditions.
On the same date, 35,118 shares at $11.29 per share were withheld by AvePoint to cover exercise price or income tax obligations related to the vesting or settlement of those awards, a non-discretionary, exempt disposition. After these transactions, Jiang directly owned 2,155,203 shares of AvePoint common stock, including both non-RSU stock and vested and unvested RSUs under prior equity awards.
AvePoint, Inc. Chief Financial Officer Caci James reported a stock compensation event involving common shares. On March 5, 2026, James received a grant or award of 17,775 shares of common stock at $11.29 per share, tied to performance-based restricted stock units under AvePoint’s 2021 Equity Incentive Plan.
On the same date, 18,005 shares of common stock at $11.29 per share were automatically withheld by AvePoint to cover income tax obligations related to the vesting or net settlement of these securities, an exempt, non-discretionary transaction. After these transactions, James directly owned 436,540 shares of AvePoint common stock, including both non-RSU shares and vested and unvested RSUs previously reported.
AvePoint, Inc. director and Chief Legal Officer Brian Michael Brown reported equity compensation-related transactions in the company’s common stock. He acquired 11,107 shares through a grant or award valued at $11.29 per share, increasing his direct holdings as part of AvePoint’s 2021 Equity Incentive Plan.
On the same date, 12,899 shares were disposed of at $11.29 per share to cover income tax withholding obligations tied to vesting securities, an exempt, non-discretionary transaction. Following these movements, Brown directly held 642,315 shares, including both common stock and previously granted restricted stock units subject to vesting and performance conditions.
AvePoint, Inc. files its annual report describing a global SaaS business focused on modern data protection and governance across major cloud ecosystems. The company’s AvePoint Confidence Platform helps organizations manage unstructured data, strengthen security, support AI initiatives, and ensure business continuity.
AvePoint reports an aggregate market value of non‑affiliate common stock of $3,259,757,209.70 as of its most recently completed second fiscal quarter and 215,466,019 common shares outstanding as of February 25, 2026. As of December 31, 2025, it served more than 28,000 end customers in over 100 countries and employed 3,443 people.
AvePoint reported strong growth and improving profitability for Q4 and full year 2025. Fourth-quarter revenue reached
For 2025, total revenue was
The company ended 2025 with cash and cash equivalents of
AvePoint, Inc. director and Chief Legal Officer Brian Michael Brown reported an exempt insider transaction related to equity compensation. On 02/04/2026, 322 shares of common stock were withheld by the company at
AvePoint, Inc. insider entities reported planned stock sales. Trusts and LLCs associated with Executive Chairman and director Gong Xunkai sold 32,002 shares of common stock on January 12, 2026 at
After these sales, entities associated with Mr. Gong beneficially owned 14,948,666 shares and 14,920,668 shares, respectively, on an indirect basis. The sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on
Form 144 discloses a planned sale of 60,000 shares of common stock of the issuer through The Charles Schwab Corporation, with an approximate sale date of 01/12/2026 on the NASDAQ. The shares to be sold are described as founders shares, acquired from the issuer on 01/02/2006, with 215,789,313 common shares stated as outstanding. The notice also lists recent sales by Xunkai Gong, including multiple common stock transactions in November and December 2025 with disclosed gross proceeds for each sale.
AvePoint director and Chief Legal Officer Brian Michael Brown reported insider equity transactions involving company stock and awards. On December 12, 2025, he acquired 21,000 shares of AvePoint common stock in connection with the exercise of stock options at a reported price of $13.89 per share. In a related exempt transaction under Rule 16b-3, 5,010 shares were withheld by AvePoint to satisfy the exercise price or tax obligations, rather than sold at his discretion. After these transactions, he beneficially owned 645,048 shares of common stock and restricted stock units in total, and held 2,265,102 stock options, all reported as directly owned.